Fund moves

Danaher Corporation (DHR): Guinness Asset Management LTD added to its stake +8,624 shares

Guinness Asset Management LTD added to its stake in Danaher Corporation, per its Q1 2025 13F.

172K
Shares reported · +8,624 vs prior quarter
0.67%
Disclosed portfolio weight
$35.3M
Reported value
Holdings as of
Mar 31, 2025
Filed
Jun 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 8, 2015CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  2. Oct 29, 2024CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  3. Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  4. Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  5. Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  6. Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  7. Apr 30, 2025Insider · 1 personInsiders: 2 sales (~$3.1M)
  8. May 12, 2025Insider · 1 personInsiders: 8 sales (~$245.9M)
  9. May 12, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  10. May 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  11. Jun 11, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  12. Jun 12, 2025CongressDisclosed sale of DHR — reported range $50,001 - $100,000

What came next

  1. Jul 22, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  2. Aug 13, 2025FDARecall: UniCel DxH 800 COULTER Cellular Analysis System, configured with the Led HGB Photometer REFs:B24802, 629029, B63322
  3. Aug 15, 2025FDAFDA device clearance: MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)
  4. Aug 20, 2025FDAFDA device clearance: MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan)
  5. Aug 22, 2025InsiderDirector sold ~$586K of DHR shares in the open market
  6. Aug 28, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  7. Sep 3, 2025FDARecall: SYNCHRON Systems Phosphorus (PHOSm) Reagent REF: 467868 For In Vitro Diagnostic Use, Rx Only.
  8. Sep 3, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  9. Sep 8, 2025FDARecall: CellMek SPS Sample Preparation System, REF: C44603. Software versions 2.2.122.0 and prior, and Instructions for Use (IFU) revisions AD and prior. These CellMek…
  10. Sep 8, 2025FDARecall: MicroScan Neg Multidrug Resistant MIC 1 REF C32368 UDI-DI code: 15099590720568 Intended Use- For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dr…
  11. Sep 9, 2025Company filing · Form 8-K · Bylaws or charter, Other newsChanged its bylaws, charter or fiscal year, and reported other company news
  12. Sep 9, 2025FDAFDA device clearance: Access anti-HAV
  13. Sep 10, 2025FDAFDA device clearance: iQ200 Series
  14. Sep 17, 2025FDARecall: SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706
  15. Sep 19, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Part Number C11137
  16. Sep 19, 2025FDARecall: DxC 500i Clinical Analyzer Modules, DxC 500 AU Module w/ISE, DxC 500i (Part Number C63522), DxC 500 AU Module, DxC 500i (Part Number C63521), and Access 2 Modu…
  17. Sep 22, 2025FDARecall: DxFLEX Flow Cytometer Catalog Number C78500 UDI-DI code: 15099590754013 The DxFLEX Flow Cytometer is intended for use as an in vitro diagnostic device for immu…
  18. Oct 1, 2025FDARecall: Beckman Coulter UniCel DxI 600, Part Numbers: A71460, A30260; Photometric Chemistry Analyzer
  19. Oct 1, 2025FDARecall: Beckman Coulter UniCel DxI 800, Part Numbers: 973100, A71456; Photometric Chemistry Analyzer
  20. Oct 14, 2025FDARecall: BECKMAN COULTER BICARBONATE REF: OSR6137 OSR6237 OSR6637 OSR6x37 Bicarbonate is a system reagent for the quantitative determination of Bicarbonate in human ser…
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Common questions

What does this filing report about Danaher Corporation (DHR) stock?

Guinness Asset Management LTD added to its stake in Danaher Corporation, per its Q1 2025 13F. Now 172K shares, $35.3M reported value, 0.67% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2025. Filed: Jun 17, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Danaher Corporation recently?

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.

Does this mean DHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data